{"id":"chemotherapy-selected-by-the-physician","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (neutropenia, anemia, thrombocytopenia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Alopecia"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Diarrhea or constipation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This entry represents a flexible, individualized chemotherapy approach where the treating physician selects the specific agent(s) based on tumor type, patient factors, and clinical context. Chemotherapy drugs typically act through DNA alkylation, cross-linking, antimetabolite activity, or mitotic inhibition to kill rapidly dividing cancer cells. The mechanism varies depending on which specific chemotherapy agent is chosen.","oneSentence":"Physician-selected chemotherapy regimens work by damaging cancer cell DNA or disrupting cell division to inhibit tumor growth.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:44:54.981Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Various solid tumors and hematologic malignancies (specific indication depends on physician selection)"}]},"trialDetails":[{"nctId":"NCT06538038","phase":"","title":"Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients","status":"RECRUITING","sponsor":"PrECOG, LLC.","startDate":"2024-09-17","conditions":"Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation, Stage III Lung Cancer","enrollment":538},{"nctId":"NCT07498231","phase":"NA","title":"COronoary Microcirculation Analysis NETwork","status":"RECRUITING","sponsor":"Medical University of Bialystok","startDate":"2025-10-10","conditions":"Coronary Artery Disease, Microcirculation Resistance, Microcirculation; Biomarkers; Myocardial Ischemia","enrollment":180},{"nctId":"NCT02758951","phase":"PHASE2, PHASE3","title":"Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Koen Rovers","startDate":"2017-06-01","conditions":"Colorectal Neoplasm, Colorectal Cancer, Colorectal Neoplasms Malignant","enrollment":358},{"nctId":"NCT07471815","phase":"PHASE2","title":"Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harbin Medical University","startDate":"2026-03-04","conditions":"Breast Cancer Triple Negative Breast Cancer","enrollment":30},{"nctId":"NCT06456463","phase":"PHASE2","title":"A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy","status":"RECRUITING","sponsor":"Stemline Therapeutics, Inc.","startDate":"2025-01-14","conditions":"Acute Myeloid Leukemia","enrollment":83},{"nctId":"NCT04302025","phase":"PHASE2","title":"A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)","status":"RECRUITING","sponsor":"Genentech, Inc.","startDate":"2020-11-06","conditions":"Non-small Cell Lung Cancer","enrollment":99},{"nctId":"NCT05464082","phase":"PHASE2","title":"Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-01-06","conditions":"Breast Cancer Recurrent","enrollment":80},{"nctId":"NCT02728076","phase":"NA","title":"MRI-Based Preoperative Accelerated Partial Breast Irradiation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2016-07-29","conditions":"Breast Cancer","enrollment":39},{"nctId":"NCT07413146","phase":"NA","title":"Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-02-24","conditions":"Minimal Residual Disease, Immunoscore, Neoadjuvant Chemotherapy","enrollment":100},{"nctId":"NCT05074290","phase":"PHASE1, PHASE2","title":"Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients","status":"RECRUITING","sponsor":"University of Florida","startDate":"2023-03-30","conditions":"Breast Cancer","enrollment":74},{"nctId":"NCT07401199","phase":"","title":"Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)","status":"NOT_YET_RECRUITING","sponsor":"Qun Zhao","startDate":"2026-02-05","conditions":"Gastric Cancer (GC), Locally Advanced Gastric Cancer","enrollment":2000},{"nctId":"NCT07394062","phase":"","title":"Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 <50% (ALCG-01)","status":"RECRUITING","sponsor":"Gazi University","startDate":"2026-02","conditions":"Nonsmall Cell Lung Cancer, Stage IV, Metastatic Nonsmall Cell Lung Cancer","enrollment":400},{"nctId":"NCT06327542","phase":"NA","title":"Group-based Integrative Pain Management in Primary Care Safety Net Clinics","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-12","conditions":"Chronic Pain","enrollment":360},{"nctId":"NCT06970912","phase":"PHASE2","title":"ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-08-01","conditions":"Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer","enrollment":393},{"nctId":"NCT07310199","phase":"NA","title":"Pharmacist-Led Transition of Care Program in the Emergency Department (Pharm TOC-ED): A Pilot Trial","status":"RECRUITING","sponsor":"Dr. Muhammad Abdul Hadi","startDate":"2026-01-19","conditions":"Transitional Care","enrollment":82},{"nctId":"NCT05464329","phase":"PHASE1","title":"Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-01-03","conditions":"Large B-cell Lymphoma, High-grade B-cell Lymphoma, Transformed B-Cell Lymphoma","enrollment":24},{"nctId":"NCT06861244","phase":"PHASE2","title":"Embryonal Tumor With Multilayered Rosettes","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-03-06","conditions":"Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos","enrollment":70},{"nctId":"NCT05830084","phase":"PHASE1","title":"Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2023-06-16","conditions":"Ewing Sarcoma","enrollment":23},{"nctId":"NCT04711824","phase":"PHASE1, PHASE2","title":"Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases","status":"RECRUITING","sponsor":"Colette Shen","startDate":"2022-03-09","conditions":"Breast Cancer, Brain Metastases, Adult","enrollment":41},{"nctId":"NCT06874790","phase":"NA","title":"RCT for Latina Mental Health Using Web-Based Apps","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-07-09","conditions":"Mental Health, Anxiety, Depression","enrollment":700},{"nctId":"NCT07269886","phase":"","title":"BIOMARKERS FOR DRUG SELECTION IN DEPRESSION","status":"COMPLETED","sponsor":"Neomente SAS","startDate":"2022-08-18","conditions":"Depression - Major Depressive Disorder","enrollment":79},{"nctId":"NCT06148506","phase":"","title":"A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-12-28","conditions":"HR+HER2- Advanced Breast Cancer","enrollment":376},{"nctId":"NCT07254455","phase":"NA","title":"CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)","status":"NOT_YET_RECRUITING","sponsor":"Tulane University","startDate":"2026-03","conditions":"Atrial Fibrillation, Heart Failure With Preserved Ejection Fraction","enrollment":900},{"nctId":"NCT07241494","phase":"NA","title":"Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment.","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2021-10-31","conditions":"Renal Impairments, Chronic Kidney Disease, Acute Kidney Disease","enrollment":160},{"nctId":"NCT03916419","phase":"PHASE2","title":"Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-06-20","conditions":"Stage IIB Non-Small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer","enrollment":26},{"nctId":"NCT06282315","phase":"PHASE3","title":"Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness","status":"RECRUITING","sponsor":"Insud Pharma","startDate":"2025-09-01","conditions":"Soil-Transmitted Helminths","enrollment":20000},{"nctId":"NCT06145308","phase":"PHASE2","title":"Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing","status":"RECRUITING","sponsor":"Peking Union Medical College","startDate":"2023-08-15","conditions":"Salivary Gland Carcinoma, Precision Therapy","enrollment":39},{"nctId":"NCT06624644","phase":"PHASE2, PHASE3","title":"A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma","status":"RECRUITING","sponsor":"Linnaeus Therapeutics, Inc.","startDate":"2025-08-06","conditions":"Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma","enrollment":135},{"nctId":"NCT04606914","phase":"PHASE2","title":"Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2021-05-27","conditions":"Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer","enrollment":70},{"nctId":"NCT01810588","phase":"PHASE2","title":"Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2012-10-16","conditions":"Hematologic Malignancies","enrollment":270},{"nctId":"NCT06490536","phase":"PHASE3","title":"The Sagittarius Trial","status":"RECRUITING","sponsor":"IFOM ETS - The AIRC Institute of Molecular Oncology","startDate":"2024-10-22","conditions":"Colon Cancer Stage II, Colon Cancer Stage III","enrollment":700},{"nctId":"NCT06783868","phase":"","title":"Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control","status":"NOT_YET_RECRUITING","sponsor":"Kansas City Heart Rhythm Research Foundation","startDate":"2025-10","conditions":"Atrial Fibrillation, Stroke","enrollment":100},{"nctId":"NCT01966367","phase":"PHASE1, PHASE2","title":"CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diane George","startDate":"2013-03","conditions":"Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia","enrollment":37},{"nctId":"NCT07120854","phase":"NA","title":"Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid.","status":"ENROLLING_BY_INVITATION","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2025-04-03","conditions":"Osteoporosis, Postmenopausal, Osteoporotic Fractures, Diphosphonates","enrollment":114},{"nctId":"NCT07054086","phase":"","title":"Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-03-01","conditions":"Esophageal Cancer","enrollment":30},{"nctId":"NCT06367088","phase":"PHASE2","title":"Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-05-01","conditions":"Triple-negative Breast Cancer, Cadonilimab","enrollment":27},{"nctId":"NCT03632135","phase":"PHASE3","title":"Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Cordgenics, LLC","startDate":"2018-05-20","conditions":"Recurrent Glioblastoma","enrollment":78},{"nctId":"NCT03804606","phase":"NA","title":"Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure","status":"TERMINATED","sponsor":"Geisinger Clinic","startDate":"2019-02-28","conditions":"Heart Failure","enrollment":100},{"nctId":"NCT06351046","phase":"NA","title":"Preventive Interventions for Chronic Pain Worsening","status":"NOT_YET_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2025-03","conditions":"Chronic Non-Cancer Pain","enrollment":44},{"nctId":"NCT06824792","phase":"PHASE4","title":"Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System","status":"NOT_YET_RECRUITING","sponsor":"NING LI","startDate":"2025-03-01","conditions":"Advanced Solid Tumors","enrollment":3000},{"nctId":"NCT03632798","phase":"PHASE3","title":"Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer","status":"WITHDRAWN","sponsor":"Cordgenics, LLC","startDate":"2018-08-01","conditions":"Recurrent Ovarian Cancer","enrollment":""},{"nctId":"NCT04257461","phase":"PHASE3","title":"A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma","status":"UNKNOWN","sponsor":"Belgian Group of Digestive Oncology","startDate":"2020-02-20","conditions":"Small Bowel Adenocarcinoma","enrollment":30},{"nctId":"NCT05906784","phase":"NA","title":"Group-based Integrative Pain Management (IPMP+ Pilot)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2023-04-28","conditions":"Chronic Pain","enrollment":44},{"nctId":"NCT03382158","phase":"","title":"International PPB/DICER1 Registry","status":"RECRUITING","sponsor":"Children's Hospitals and Clinics of Minnesota","startDate":"2016-12-06","conditions":"Pleuropulmonary Blastoma, Sertoli-Leydig Cell Tumor, DICER1 Syndrome","enrollment":3400},{"nctId":"NCT04136769","phase":"NA","title":"Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer","status":"TERMINATED","sponsor":"Ulrich Ronellenfitsch, MD","startDate":"2020-02-07","conditions":"Pancreas Cancer","enrollment":3},{"nctId":"NCT04450706","phase":"NA","title":"Functional Precision Oncology for Metastatic Breast Cancer","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-02-16","conditions":"HER2-negative Breast Cancer","enrollment":15},{"nctId":"NCT03839823","phase":"PHASE2","title":"Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-02-25","conditions":"Breast Cancer","enrollment":222},{"nctId":"NCT05118022","phase":"NA","title":"Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)","status":"COMPLETED","sponsor":"National Defense Medical Center, Taiwan","startDate":"2022-01-01","conditions":"Hyperkalemia, Hypokalemia","enrollment":14989},{"nctId":"NCT06523673","phase":"PHASE3","title":"Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-09","conditions":"Metastatic Non-Small Cell Lung Cancer, NSCLC Stage IV, OligoProgressive Metastatic Disease","enrollment":104},{"nctId":"NCT03949283","phase":"PHASE3","title":"Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cordgenics, LLC","startDate":"2019-07-26","conditions":"Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer","enrollment":150},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT06391892","phase":"PHASE3","title":"Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery","status":"RECRUITING","sponsor":"Elisabethinen Hospital","startDate":"2024-01-11","conditions":"Pancreatic Cancer, Circulating Tumor Cell, Predictive Cancer Model","enrollment":100},{"nctId":"NCT06151743","phase":"PHASE2","title":"Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2024-01-18","conditions":"Locally Advanced Hypopharyngeal Carcinoma","enrollment":32},{"nctId":"NCT05861830","phase":"PHASE3","title":"Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-05-15","conditions":"Advanced Breast Cancer","enrollment":80},{"nctId":"NCT04074031","phase":"NA","title":"Transcranial Ultrasound Therapy of Essential Tremor","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-01-07","conditions":"Essential Tremor","enrollment":15},{"nctId":"NCT04592861","phase":"PHASE3","title":"Carbon Ion RT for Locally Advanced Pancreatic Cancer","status":"TERMINATED","sponsor":"Albert Einstein College of Medicine","startDate":"2020-11-01","conditions":"Pancreatic Cancer","enrollment":5},{"nctId":"NCT05948462","phase":"PHASE2","title":"Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib","status":"WITHDRAWN","sponsor":"SCRI Development Innovations, LLC","startDate":"2023-11","conditions":"Lung Cancer, Non-small Cell Lung Cancer","enrollment":""},{"nctId":"NCT01849874","phase":"PHASE3","title":"A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer","status":"TERMINATED","sponsor":"Pfizer","startDate":"2013-06-27","conditions":"Low-grade Serous Ovarian Cancer, Low-grade Serous Fallopian Tube Cancer, Low-grade Serous Peritoneal Cancer","enrollment":341},{"nctId":"NCT05595395","phase":"NA","title":"The Enteral Resuscitation In Intensive Care Pilot- Study","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2023-02-13","conditions":"Electrolyte Imbalance, Volume Overload, Hyperosmolality","enrollment":64},{"nctId":"NCT01345539","phase":"PHASE2","title":"Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation","status":"TERMINATED","sponsor":"Steven Burton","startDate":"2013-06-07","conditions":"Oligometastatic Disease","enrollment":24},{"nctId":"NCT02661035","phase":"PHASE2","title":"Allo HSCT Using RIC for Hematological Diseases","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2017-03-09","conditions":"Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia","enrollment":156},{"nctId":"NCT02847130","phase":"","title":"Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2016-11-21","conditions":"Acute Lymphoblastic Leukemia, B-Cell Non-Hodgkin Lymphoma, Childhood Acute Myeloid Leukemia","enrollment":530},{"nctId":"NCT05003726","phase":"NA","title":"Non-pharmacological Treatment and Pharmacological Treatment for Non-acute Lumbar Disc Herniation","status":"COMPLETED","sponsor":"Jaseng Hospital of Korean Medicine","startDate":"2021-10-15","conditions":"Lumbar Disc Herniation, Radiculopathy Lumbar","enrollment":36},{"nctId":"NCT03775239","phase":"NA","title":"Mindfulness as Treatment of Sexological Problems","status":"COMPLETED","sponsor":"Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital","startDate":"2018-07-25","conditions":"Sexual Dysfunction, Sexual Dysfunctions, Psychological, Sexual Dysfunctions, Physiological","enrollment":34},{"nctId":"NCT05233696","phase":"PHASE2","title":"Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC","status":"WITHDRAWN","sponsor":"University of Colorado, Denver","startDate":"2022-01-04","conditions":"Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma","enrollment":""},{"nctId":"NCT04833270","phase":"NA","title":"Pragmatic Randomized Controlled Trial of Non-pharmacological Treatment for Lumbar Disc Herniation : A Pilot Study","status":"COMPLETED","sponsor":"Jaseng Hospital of Korean Medicine","startDate":"2021-07-09","conditions":"Lumbar Disc Prolapse With Radiculopathy","enrollment":30},{"nctId":"NCT05547282","phase":"NA","title":"Low-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy Failure","status":"UNKNOWN","sponsor":"Jiandong Zhang","startDate":"2022-10-01","conditions":"Cancer Patients","enrollment":20},{"nctId":"NCT03602885","phase":"NA","title":"EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2018-09-01","conditions":"Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Colorectal Cancer","enrollment":10},{"nctId":"NCT01366183","phase":"","title":"Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer","status":"UNKNOWN","sponsor":"Gynecologic Oncology Group","startDate":"2011-08-15","conditions":"Stage I Ovarian Cancer AJCC v6 and v7, Stage IA Fallopian Tube Cancer AJCC v6 and v7, Stage IB Fallopian Tube Cancer AJCC v6 and v7","enrollment":290},{"nctId":"NCT03394885","phase":"PHASE1, PHASE2","title":"Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-06-19","conditions":"Ovarian Cancer, Ovarian Neoplasms","enrollment":18},{"nctId":"NCT04937933","phase":"PHASE4","title":"Effect of Coolant Spray on Traumatic Rib Pain of Geriatric Patients","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2019-10-01","conditions":"Thorax; Fracture, Pain; Thorax, Thoracic, Spine, With Radicular and Visceral Pain","enrollment":101},{"nctId":"NCT02551263","phase":"","title":"Eribulin Treatment as 1st-line or 2nd-line Chemotherapy for HER2-negative Hormone-resistant Inoperable or Recurrent Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","startDate":"2015-07-22","conditions":"Breast Cancer","enrollment":201},{"nctId":"NCT04061642","phase":"NA","title":"A Feasibility Study of an AI-Powered Clinical Decision Aid for Personalized Depression Treatment Selection","status":"COMPLETED","sponsor":"Aifred Health Inc.","startDate":"2019-12-16","conditions":"Depression","enrollment":17},{"nctId":"NCT02601521","phase":"NA","title":"Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2015-11","conditions":"Smoking Cessation, Tobacco Use Disorder","enrollment":106},{"nctId":"NCT02117024","phase":"PHASE2","title":"A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer","status":"TERMINATED","sponsor":"Heat Biologics","startDate":"2014-07","conditions":"Non Small Cell Lung Cancer","enrollment":66},{"nctId":"NCT03611985","phase":"PHASE1, PHASE2","title":"Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients","status":"WITHDRAWN","sponsor":"University of Florida","startDate":"2020-03","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT03348696","phase":"PHASE4","title":"Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2018-02-28","conditions":"Early-stage Breast Cancer, Pain Syndrome","enrollment":124},{"nctId":"NCT00003196","phase":"NA","title":"Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1997-09","conditions":"Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma","enrollment":63},{"nctId":"NCT02575612","phase":"NA","title":"Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer","status":"COMPLETED","sponsor":"Heidelberg University","startDate":"2014-07","conditions":"Breast Neoplasms","enrollment":50},{"nctId":"NCT01576692","phase":"PHASE1","title":"Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2012-04","conditions":"Neuroblastoma","enrollment":34},{"nctId":"NCT03175341","phase":"PHASE1, PHASE2","title":"Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer","status":"UNKNOWN","sponsor":"Academic Emergency County Hospital Sibiu","startDate":"2018-10-01","conditions":"Breast Cancer","enrollment":30},{"nctId":"NCT00382018","phase":"PHASE3","title":"S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2006-10","conditions":"Breast Cancer","enrollment":624},{"nctId":"NCT01735448","phase":"","title":"Improving Health for Aboriginal People Through Tobacco Related Research","status":"COMPLETED","sponsor":"The Queen Elizabeth Hospital","startDate":"2013-03","conditions":"Tobacco Dependence","enrollment":16},{"nctId":"NCT01014312","phase":"NA","title":"Treatment for Depressed Primary Care Patients","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2009-09-01","conditions":"Depression","enrollment":11},{"nctId":"NCT02659345","phase":"NA","title":"Evaluating the Effectiveness of Art Therapy on Mood, Anxiety, and Pain Levels in Cancer Patients","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2015-05","conditions":"Cancer","enrollment":50},{"nctId":"NCT00737243","phase":"PHASE2","title":"Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site","status":"COMPLETED","sponsor":"SCRI Development Innovations, LLC","startDate":"2008-08","conditions":"Carcinoma","enrollment":289},{"nctId":"NCT01664533","phase":"","title":"An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line Therapy","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-09","conditions":"Non-Squamous Non-Small Cell Lung Cancer","enrollment":57},{"nctId":"NCT01050946","phase":"PHASE2","title":"Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit","status":"TERMINATED","sponsor":"Medical College of Wisconsin","startDate":"2009-07","conditions":"Leukemia, Lymphocytic, Acute, Leukemia, Lymphocytic, Chronic, Leukemia, Myelocytic, Acute","enrollment":1},{"nctId":"NCT01454180","phase":"PHASE2","title":"Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets","status":"COMPLETED","sponsor":"Centro Nacional de Investigaciones Oncologicas CARLOS III","startDate":"2011-10","conditions":"Advanced Pancreatic Carcinoma","enrollment":31},{"nctId":"NCT01703910","phase":"PHASE2","title":"Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic","status":"COMPLETED","sponsor":"Centro Nacional de Investigaciones Oncologicas CARLOS III","startDate":"2012-11","conditions":"Adenocarcinoma of Colon, Adenocarcinoma of Rectum, Metastatic Disease","enrollment":29},{"nctId":"NCT00391586","phase":"PHASE2","title":"Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung","status":"TERMINATED","sponsor":"New Mexico Cancer Research Alliance","startDate":"2006-07","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":45},{"nctId":"NCT01850277","phase":"PHASE4","title":"Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study","status":"UNKNOWN","sponsor":"National Institute of Cardiology, Warsaw, Poland","startDate":"2013-10","conditions":"Atrial Fibrillation, Heart Failure","enrollment":60},{"nctId":"NCT02353988","phase":"PHASE2","title":"AR-inhibitor Bicalutamide in Treating Patients With TNBC","status":"UNKNOWN","sponsor":"Jinling Hospital, China","startDate":"2015-01","conditions":"Breast Neoplasms","enrollment":60},{"nctId":"NCT02013453","phase":"PHASE2","title":"A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer","status":"WITHDRAWN","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2013-12","conditions":"Cancer of Head and Neck","enrollment":""},{"nctId":"NCT00158327","phase":"PHASE3","title":"Telephone-Based Care Management Program for Individuals With Anxiety Disorders","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2004-03","conditions":"Anxiety Disorders, Panic Disorder","enrollment":360},{"nctId":"NCT01004510","phase":"PHASE2","title":"Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer","status":"TERMINATED","sponsor":"Peter Bushunow MD","startDate":"2009-11","conditions":"Malignant Pleural Effusion, Non Small Cell Lung Cancer","enrollment":3},{"nctId":"NCT00101868","phase":"NA","title":"Value of Technology to Transfer Discharge Information","status":"COMPLETED","sponsor":"Agency for Healthcare Research and Quality (AHRQ)","startDate":"2004-12","conditions":"Information Dissemination, Interprofessional Relations","enrollment":631},{"nctId":"NCT00707382","phase":"NA","title":"Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment","status":"COMPLETED","sponsor":"Gesche Jurgens","startDate":"2008-02","conditions":"Schizophrenia","enrollment":311},{"nctId":"NCT00550966","phase":"NA","title":"Efficacy of a Psychoeducative Program for Improving Quality of Life in Fibromyalgic Patients [Study Protocol]","status":"UNKNOWN","sponsor":"Institut Catala de Salut","startDate":"2007-09","conditions":"Fibromyalgia","enrollment":109}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":925,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Chemotherapy selected by the physician","genericName":"Chemotherapy selected by the physician","companyName":"Peking Union Medical College Hospital","companyId":"peking-union-medical-college-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Physician-selected chemotherapy regimens work by damaging cancer cell DNA or disrupting cell division to inhibit tumor growth. Used for Various solid tumors and hematologic malignancies (specific indication depends on physician selection).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}